Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications primarily used for managing type 2 diabetes and, in some formulations, for chronic weight management
Because it targets only one receptor, microdosing is relatively straightforward
Within a year of treatment, many individuals achieve their weight loss and health goals, and they tend to have better long-term success in maintaining their results compared to those who have not used semaglutide GLP-1
Eating too close to injection time can worsen nausea
"While some plant compounds may indirectly influence GLP-1 pathways or mimic some GLP-1 effects, they are not equivalent to pharmaceutical GLP-1 receptor agonists," says Kumar
Symptoms may include swelling beneath the skin or trouble breathing